MDVZX
Price
$8.28
Change
+$0.04 (+0.49%)
Updated
Jun 26 closing price
Net Assets
144.01M
RMEBX
Price
$58.60
Change
+$0.43 (+0.74%)
Updated
Jun 26 closing price
Net Assets
106.24B
Interact to see
Advertisement

MDVZX vs RMEBX

Header iconMDVZX vs RMEBX Comparison
Open Charts MDVZX vs RMEBXBanner chart's image
Manning & Napier Disciplined Value Z
Price$8.28
Change+$0.04 (+0.49%)
VolumeN/A
Net Assets144.01M
American Funds American Mutual R2E
Price$58.60
Change+$0.43 (+0.74%)
VolumeN/A
Net Assets106.24B
MDVZX vs RMEBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
MDVZX vs. RMEBX commentary
Jun 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MDVZX is a StrongBuy and RMEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 106B vs. MDVZX (144M). MDVZX pays higher dividends than RMEBX: MDVZX (2.28) vs RMEBX (1.16). MDVZX was incepted earlier than RMEBX: MDVZX (6 years) vs RMEBX (11 years). RMEBX (1.07) is less costly to investors than MDVZX (0.45). MDVZX is a more actively managed with annual turnover of: 58.00 vs. RMEBX (31.00). RMEBX has a lower initial minimum investment than MDVZX: RMEBX (250) vs MDVZX (1000000). RMEBX annual gain was more profitable for investors over the last year : 9.50 vs. MDVZX (0.27). RMEBX return over 5 years is better than : 62.71 vs. MDVZX (34.28).
MDVZXRMEBXMDVZX / RMEBX
Total Expense Ratio0.451.0742%
Annual Report Gross Expense Ratio0.451.0742%
Fund Existence6 years11 years-
Gain YTD1.7257.31524%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets144M106B0%
Annual Yield % from dividends2.281.16197%
Returns for 1 year0.279.503%
Returns for 3 years5.5525.8821%
Returns for 5 years34.2862.7155%
Returns for 10 yearsN/A74.51-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VIR5.310.12
+2.31%
Vir Biotechnology
SPRO2.90N/A
N/A
Spero Therapeutics
AMED98.03-0.05
-0.05%
Amedisys
SHG44.16-0.24
-0.54%
Shinhan Financial Group Co Ltd
DFDV17.94-0.92
-4.88%
DeFi Development Corp